Hans Hull - Net Worth and Insider Trading
Hans Hull Net Worth
The estimated net worth of Hans Hull is at least $4 Million dollars as of 2024-11-28. Hans Hull is the Chief Business Officer of Pliant Therapeutics Inc and owns about 259,285 shares of Pliant Therapeutics Inc (PLRX) stock worth over $4 Million. Details can be seen in Hans Hull's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hans Hull has not made any transactions after 2024-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hans Hull
Hans Hull Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hans Hull owns 2 companies in total, including Adverum Biotechnologies Inc (ADVM) , and Pliant Therapeutics Inc (PLRX) .
Click here to see the complete history of Hans Hull’s form 4 insider trades.
Insider Ownership Summary of Hans Hull
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADVM | Adverum Biotechnologies Inc | 2014-07-30 | SVP & Legal and Corp. Dev. |
| PLRX | Pliant Therapeutics Inc | 2024-07-10 | Chief Business Officer |
Hans Hull Latest Holdings Summary
Hans Hull currently owns a total of 1 stock. Hans Hull owns 259,285 shares of Pliant Therapeutics Inc (PLRX) as of July 10, 2024, with a value of $4 Million.
Latest Holdings of Hans Hull
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLRX | Pliant Therapeutics Inc | 2024-07-10 | 259,285 | 13.53 | 3,508,126 |
Holding Weightings of Hans Hull
Hans Hull Form 4 Trading Tracker
According to the SEC Form 4 filings, Hans Hull has made a total of 6 transactions in Pliant Therapeutics Inc (PLRX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Pliant Therapeutics Inc is the sale of 9,900 shares on July 10, 2024, which brought Hans Hull around $114,444.
Insider Trading History of Hans Hull
- 1
Hans Hull Trading Performance
Hans Hull Ownership Network
Hans Hull Owned Company Details
What does Adverum Biotechnologies Inc do?
Who are the key executives at Adverum Biotechnologies Inc?
Hans Hull is the SVP & Legal and Corp. Dev. of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .
Adverum Biotechnologies Inc (ADVM) Insider Trades Summary
Over the past 18 months, Hans Hull made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 302,064 shares made by Braden Michael Leonard , a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , and a net purchase of 100,000 shares made by James Paul Scopa .
In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 620 shares of Adverum Biotechnologies Inc (ADVM) were sold and 335,064 shares were bought by its insiders, resulting in a net purchase of 334,444 shares.
Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adverum Biotechnologies Inc Insider Transactions
Hans Hull Mailing Address
Above is the net worth, insider trading, and ownership report for Hans Hull. You might contact Hans Hull via mailing address: C/o Avalanche Biotechnologies, Inc., 1035 O'brien Drive, Suite A, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
